PHASE-II STUDY OF AMSACRINE AND HIGH-DOSE CYTARABINE FOR RESISTANT ACUTE MYELOGENOUS LEUKEMIA

被引:0
|
作者
DECKER, RW
HO, WG
CHAMPLIN, RE
机构
[1] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT MED,DIV HEMATOL ONCOL,TRANSPLANTAT BIOL PROGRAM,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024
来源
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 09期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:881 / 882
页数:2
相关论文
共 50 条
  • [1] A phase I/II study of high-dose cytarabine and topotecan for the treatment of resistant acute myelogenous leukemia.
    Schiller, G
    Hepner, A
    Lee, M
    Sawyers, C
    Paquette, R
    Territo, M
    [J]. BLOOD, 1998, 92 (10) : 218B - 218B
  • [2] RANDOMIZED TRIAL OF HIGH-DOSE CYTARABINE VERSUS AMSACRINE IN ACUTE MYELOGENOUS LEUKEMIA IN RELAPSE - A LEUKEMIA INTERGROUP STUDY
    VOGLER, WR
    PREISLER, HD
    WINTON, EF
    GOTTLIEB, AJ
    GOLDBERG, J
    BRENNAN, J
    GRUNWALD, H
    RAI, K
    BROWMAN, G
    MILLER, KB
    CHERVENICK, P
    AZARNIA, N
    [J]. CANCER TREATMENT REPORTS, 1986, 70 (04): : 455 - 459
  • [3] AMSACRINE WITH HIGH-DOSE CYTARABINE IN ACUTE-LEUKEMIA
    ZITTOUN, R
    BURY, J
    STRYCKMANS, P
    LOWENBERG, B
    PEETERMANS, M
    ROZENDAAL, KY
    HAANEN, C
    KERKHOFS, M
    JEHN, U
    WILLEMZE, R
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (12): : 1447 - 1448
  • [4] HIGH-DOSE CYTARABINE IN ACUTE MYELOGENOUS LEUKEMIA
    ZITTOUN, R
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 42
  • [5] TREATMENT OF ACUTE-LEUKEMIA WITH AMSACRINE AND HIGH-DOSE CYTARABINE
    ARLIN, ZA
    GADDIPATI, J
    AHMED, T
    MITTELMAN, A
    FRIEDLAND, M
    RIEBER, E
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (09): : 1001 - 1002
  • [6] HIGH-DOSE AMSACRINE (AMSA) THERAPY OF RELAPSED AND REFRACTORY ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHASE-II STUDY
    CASSILETH, PA
    LYMAN, GH
    BENNETT, JM
    GLICK, JH
    OKEN, MM
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04): : 361 - 363
  • [7] A PHASE-II PILOT TRIAL OF HIGH-DOSE HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    KOLITZ, JE
    KEMPIN, SJ
    SCHLUGER, A
    WONG, GY
    BERMAN, E
    JHANWAR, S
    ARLIN, ZA
    GEE, T
    CLARKSON, BD
    [J]. SEMINARS IN ONCOLOGY, 1992, 19 (03) : 27 - 33
  • [8] HIGH-DOSE CYTARABINE FOR THE TREATMENT OF BLASTIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
    HERZIG, RH
    PHILLIPS, GL
    LAZARUS, HM
    WOLFF, SN
    HERZIG, GP
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 881 - 883
  • [9] AMSA - A PHASE-II TRIAL IN RESISTANT AND RECURRENT ACUTE MYELOGENOUS LEUKEMIA
    BOCCIA, R
    ZIGHELBOIM, J
    CHAMPLIN, RE
    CHUN, CK
    GALE, RP
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (03): : 178 - 179
  • [10] A NEW REGIMEN OF AMSACRINE WITH HIGH-DOSE CYTARABINE IS SAFE AND EFFECTIVE THERAPY FOR ACUTE-LEUKEMIA
    ARLIN, ZA
    AHMED, T
    MITTELMAN, A
    FELDMAN, E
    MEHTA, R
    WEINSTEIN, P
    RIEBER, E
    SULLIVAN, P
    BASKIND, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) : 371 - 375